On Oct 22, 2013, Andrew Spiegel, Executive Director of the Global Colon Cancer Association, testified in support of biosimilar legislation under consideration in IN.
On Oct 22, 2013, Andrew Spiegel, Executive Director of the Global Colon Cancer Association, testified in support of biosimilar legislation under consideration in IN.